{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:14:31Z","timestamp":1779894871442,"version":"3.53.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.clml.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T21:23:06Z","timestamp":1371244986000},"page":"392-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell\/Histiocyte-Rich Large B-Cell Lymphoma?"],"prefix":"10.1016","volume":"13","author":[{"given":"Nicholas A.","family":"Barber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Fausto R.","family":"Loberiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamarija M.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P.","family":"Holdeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliriza B.","family":"Esfahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Gregory","family":"Bociek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2013.03.004_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1634\/theoncologist.2009-0099","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma","volume":"14","author":"Lee","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2013.03.004_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"323","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma","author":"Poppema","year":"2008"},{"key":"10.1016\/j.clml.2013.03.004_bib3","first-page":"300","article-title":"Nodular lymphocyte-predominant hodgkin lymphoma or T-cell\/histiocyte rich large B-cell lymphoma: the problem in \u201cgrey zone\u201d lymphomas","volume":"1","author":"Zhao","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"issue":"suppl 1","key":"10.1016\/j.clml.2013.03.004_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workship on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyte-rich B cell lymphoma","volume":"13","author":"R\u00fcdiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2013.03.004_bib5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1080\/1042819031000123528","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group","volume":"44","author":"Huang","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2013.03.004_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2013.03.004_bib7","first-page":"4464","article-title":"Postitron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose","volume":"91","author":"R\u04e7mer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.03.004_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hon.782","article-title":"Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake","volume":"24","author":"Hutchings","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2013.03.004_bib9","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2013.03.004_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2013.03.004_bib11","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Hodgkin Lymphoma, version 3.2012. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed: May 6,\u00a02013."},{"key":"10.1016\/j.clml.2013.03.004_bib12","first-page":"1659","article-title":"Glucose-normalized standardized uptake value from 18F-FDG PET in classifying lymphomas","volume":"46","author":"Wong","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clml.2013.03.004_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cyto.b.20463","article-title":"Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report","volume":"76","author":"Naushad","year":"2009","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:24:28Z","timestamp":1761870268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265013000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S2152265013000980"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2013.03.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Functional Imaging Distinguish Nodular Lymphocyte-Predominant Hodgkin Lymphoma From T-Cell\/Histiocyte-Rich Large B-Cell Lymphoma?","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}